Loss of EZH2 Protein Expression in Myelodysplastic Syndrome Correlates with EZH2 Mutation and Portends a Worse Outcome

Authors

Ali Sakhdari, University of Texas MD Anderson Cancer Center
Caleb Class, University of Texas MD Anderson Cancer Center
Guillermo Montalban-Bravo, University of Texas MD Anderson Cancer Center
Koji Sasaki, University of Texas MD Anderson Cancer Center
Carlos Bueso-Ramos, University of Texas MD Anderson Cancer Center
Keyur Patel, University of Texas MD Anderson Cancer Center
Joseph Khoury, University of Texas MD Anderson Cancer Center
Hagop Kantarjian, University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero, University of Texas MD Anderson Cancer Center
L. Medeiros, University of Texas MD Anderson Cancer Center
Rashmi Kanagal-Shamanna, University of Texas MD Anderson Cancer Center

Document Type

Article

Publication Date

November 2019

Publication Title

Blood

First Page

3016

Last Page

3016

DOI

10.1182/BLOOD-2019-131774

Recommended Citation

Sakhdari, Ali; Class, Caleb; Montalban-Bravo, Guillermo; Sasaki, Koji; Bueso-Ramos, Carlos; Patel, Keyur; Khoury, Joseph; Kantarjian, Hagop; Garcia-Manero, Guillermo; Medeiros, L.; and Kanagal-Shamanna, Rashmi, "Loss of EZH2 Protein Expression in Myelodysplastic Syndrome Correlates with EZH2 Mutation and Portends a Worse Outcome" (2019). Scholarship and Professional Work – COPHS. 280.
https://digitalcommons.butler.edu/cophs_papers/280